Condition
Left Main Coronary Artery Stenosis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Left Main Coronary Artery Stenosis clinical trials that are recruiting, at sites in 2 countries (most in Switzerland (1), Turkey (Türkiye) (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Crossover vs Accurate Ostial Stenting for Left Main Bifurcation Lesions
This observational study tests two stenting strategies for ostial lesions in the left main coronary artery to see which approach works better for patients with left main bifurcation disease.
-
Ultrathin sirolimus‑eluting stents with P2Y12‑only single antiplatelet therapy versus conventional dual antiplatelet therapy for left main coronary artery disease
This trial will test whether using an ultrathin‑strut sirolimus‑eluting stent followed by P2Y12‑only single antiplatelet therapy after a short period of dual therapy works as well as standard dual antiplatelet therapy for adults treated with PCI of the unprotected left main coronary artery.
Related topics
Quick answers
How many Left Main Coronary Artery Stenosis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Switzerland (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.